ASCLS eNewsBytes

• Experimental RNA Treatment Shows Surprising DNA Repair Power December 12, 2025
  Scientists have developed an experimental drug, TY1, which aids in repairing damaged DNA and restoring injured tissue, based on research into molecular messages from heart cells that promote healing after injury.
• Augmented Reality can Transform Hospital Infection Training December 12, 2025
  Health care professionals often lack sufficient knowledge about preventing airborne infections. To address this, Dassault Systèmes and Saint-Louis Hospital AP-HP have created an augmented reality system that aids staff in visualizing these infections.
• FDA Approves Gepotidacin for Uncomplicated Urogenital Gonorrhea December 12, 2025
  FDA has expanded approval for gepotidacin as an oral treatment for uncomplicated urogenital gonorrhea in patients aged 12 and older, weighing at least 45 kg, with limited or no alternative options.
• Common Childhood Virus Causes DNA Damage Driving Bladder Cancer December 12, 2025
  BK virus, often contracted in childhood, may contribute to the later development of bladder cancer. This finding could lead to new prevention strategies for bladder cancer, particularly benefiting kidney transplant recipients who face increased risks of severe complications from the virus.
• Long COVID Involves Activation of Proinflammatory And Immune Exhaustion Pathways December 12, 2025
  Long COVID consists of a range of chronic symptoms following acute SARS-CoV-2 infection. Potential causes include persistent virus, tissue damage, autoimmunity, endocrine insufficiency, immune dysfunction and complement activation.